First Alabama Medical Cannabis Dispensary to Open Next Month – Ganjapreneur
The first Alabama medical cannabis dispensary open next month represents a significant milestone in cannabis medicine. This development has important clinical implications for practitioners and patients alike. Clinicians should monitor this evolving area…
THCA Flower Sales Resume in Texas Following Judge’s TRO
THCA flower sales Texas have resumed after a judge granted a temporary restraining order (TRO). This development affects cannabis business operations and clinical considerations in Texas. Clinicians and industry stakeholders should monitor ongoing…
RFK and Dr. Oz Back Lawsuit Challenging Medicare Hemp Coverage
The medicare hemp coverage lawsuit challenges access to hemp-derived cannabis products under federal insurance. This legal battle could affect clinicians' ability to recommend cannabinoid therapies to Medicare beneficiaries. Understanding this lawsuit is…
Medical Cannabis Market Growth and Clinical Research Outlook 2026-2033
The medical cannabis market growth 2026 is driven by intensified clinical research and development of pharmaceutical-grade products. Clinicians must stay informed about emerging evidence to guide patient care. This evolving landscape promises more…
Proposed Rule Would Allow Expansion of Cannabis Research in Missouri
Missouri cannabis research expansion is proposed to enable new research facilities focused on cannabis clinical studies. This rule aims to remove restrictions limiting research infrastructure and accelerate evidence development. Clinicians could benefit…
How a tiny First Nations community in N.S. is grappling with the burning issue of cannabis
This article examines first nations cannabis policy and its impact on a tiny community in Nova Scotia. The focus is on clinical relevance and emerging challenges. Clinicians and policymakers should monitor these developments closely.
Cannabis Stock ACB Down 19% YTD: Should You Buy the Dip? – April 13, 2026
The 2026 cannabis stock market trends show ACB down 19% YTD, raising questions about investment opportunities. This analysis covers key factors influencing cannabis stock performance. Investors and clinicians should consider these trends carefully.
Join WELLWVU’s 420 Panel Cannabis Education Event at WVU
Attend the cannabis education event hosted by WELLWVU's 420 panel, focusing on cannabis medicine and clinical practice. This event is essential for WVU students seeking to understand emerging cannabis research. Clinicians and students alike should…
Poll: Pennsylvanians Across Party Lines Support a Regulated Cannabis Marketplace
A recent poll highlights strong support for a regulated cannabis marketplace across party lines in Pennsylvania. This regulated cannabis marketplace reflects growing public interest in cannabis policy. Clinicians and policymakers should consider these…
France Extends Experimental Medical Cannabis Access Until 2027
France medical cannabis access extension has been announced, allowing experimental use until 2027. This development is important for cannabis medicine and clinical practice. Clinicians should monitor emerging evidence related to this extension.